# Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study

> **NCT04288193** · — · WITHDRAWN · sponsor: **Tabula Rasa HealthCare**

## Conditions studied

- Behavioral and Psychiatric Symptoms of Dementia
- Insomnia

## Interventions

- **DRUG:** Recommendation to Deprescribe

## Key facts

- **NCT ID:** NCT04288193
- **Lead sponsor:** Tabula Rasa HealthCare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-19
- **Primary completion:** 2022-05-18
- **Final completion:** 2022-05-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in personnel, unable to begin project.
- **Last updated:** 2022-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04288193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04288193, "Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04288193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*